Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema

BACKGROUND: For safe and efficacious treatment of hereditary angioedema, C1 esterase inhibitor (C1-INH) concentrates should have high purity and high amounts of functional protein. As no pharmacopoeia requirements exist for C1-INH concentrate lot release, biochemical characteristics as declared by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feussner, Annette, Kalina, Uwe, Hofmann, Peter, Machnig, Thomas, Henkel, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Blood Components
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285325/
https://www.ncbi.nlm.nih.gov/pubmed/24805006
http://dx.doi.org/10.1111/trf.12678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285325/
https://www.ncbi.nlm.nih.gov/pubmed/24805006
http://dx.doi.org/10.1111/trf.12678

Ejemplares similares